While both the United States and Europe strive to provide optimal cancer care, their systems differ substantially. The US often emphasizes innovative treatments, sometimes leading to greater costs. In contrast, European systems tend to prioritize proactive care and affordability, focusing on early screening. This can result in varied patient experi